Morgan Stanley’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.03M Sell
831,770
-2,539,962
-75% -$3.15M ﹤0.01% 5079
2025
Q1
$3.98M Sell
3,371,732
-2,279,826
-40% -$2.69M ﹤0.01% 4119
2024
Q4
$10.3M Buy
5,651,558
+1,759,016
+45% +$3.22M ﹤0.01% 3378
2024
Q3
$6.62M Buy
3,892,542
+812,786
+26% +$1.38M ﹤0.01% 3739
2024
Q2
$4.22M Buy
3,079,756
+1,176,905
+62% +$1.61M ﹤0.01% 4025
2024
Q1
$7.14M Sell
1,902,851
-20,316,313
-91% -$76.2M ﹤0.01% 3613
2023
Q4
$218M Buy
22,219,164
+19,933,963
+872% +$196M 0.01% 1101
2023
Q3
$19.1M Buy
2,285,201
+549,604
+32% +$4.59M ﹤0.01% 2503
2023
Q2
$23.1M Sell
1,735,597
-318,931
-16% -$4.24M ﹤0.01% 2333
2023
Q1
$23.8M Buy
2,054,528
+773,836
+60% +$8.96M ﹤0.01% 2230
2022
Q4
$10.5M Sell
1,280,692
-1,294,188
-50% -$10.6M ﹤0.01% 3039
2022
Q3
$14.9M Sell
2,574,880
-641,686
-20% -$3.73M ﹤0.01% 2524
2022
Q2
$14.2M Buy
3,216,566
+1,267,924
+65% +$5.6M ﹤0.01% 2670
2022
Q1
$17.7M Buy
1,948,642
+840,967
+76% +$7.65M ﹤0.01% 2246
2021
Q4
$22.7M Sell
1,107,675
-438,882
-28% -$8.98M ﹤0.01% 2022
2021
Q3
$39.5M Buy
1,546,557
+604,726
+64% +$15.5M 0.01% 1460
2021
Q2
$32.9M Buy
941,831
+85,278
+10% +$2.98M ﹤0.01% 1653
2021
Q1
$28.5M Buy
856,553
+340,371
+66% +$11.3M ﹤0.01% 1597
2020
Q4
$13.4M Buy
516,182
+308,103
+148% +$7.99M ﹤0.01% 2211
2020
Q3
$2.05M Sell
208,079
-1,073,575
-84% -$10.6M ﹤0.01% 3633
2020
Q2
$4.42M Buy
1,281,654
+1,157,197
+930% +$3.99M ﹤0.01% 2800
2020
Q1
$381K Sell
124,457
-1,450,061
-92% -$4.44M ﹤0.01% 4537
2019
Q4
$8.09M Buy
1,574,518
+684,917
+77% +$3.52M ﹤0.01% 2660
2019
Q3
$4.59M Buy
889,601
+448,151
+102% +$2.31M ﹤0.01% 2957
2019
Q2
$2.67M Buy
441,450
+215,976
+96% +$1.31M ﹤0.01% 3540
2019
Q1
$1.63M Sell
225,474
-80,464
-26% -$582K ﹤0.01% 3750
2018
Q4
$2.26M Buy
305,938
+73,283
+31% +$542K ﹤0.01% 3660
2018
Q3
$1.26M Sell
232,655
-66,420
-22% -$359K ﹤0.01% 4356
2018
Q2
$1.06M Buy
299,075
+19,954
+7% +$70.9K ﹤0.01% 4598
2018
Q1
$573K Buy
279,121
+30,269
+12% +$62.1K ﹤0.01% 4925
2017
Q4
$657K Buy
248,852
+76,594
+44% +$202K ﹤0.01% 4820
2017
Q3
$904K Buy
172,258
+70,285
+69% +$369K ﹤0.01% 4497
2017
Q2
$363K Sell
101,973
-671,546
-87% -$2.39M ﹤0.01% 4995
2017
Q1
$4M Buy
773,519
+435,774
+129% +$2.25M ﹤0.01% 3099
2016
Q4
$1.28M Buy
337,745
+281,224
+498% +$1.07M ﹤0.01% 4276
2016
Q3
$507K Sell
56,521
-61,363
-52% -$550K ﹤0.01% 4515
2016
Q2
$828K Buy
117,884
+24,898
+27% +$175K ﹤0.01% 4117
2016
Q1
$791K Sell
92,986
-284,163
-75% -$2.42M ﹤0.01% 4132
2015
Q4
$4.95M Buy
377,149
+358,072
+1,877% +$4.7M ﹤0.01% 2669
2015
Q3
$70K Buy
19,077
+4,955
+35% +$18.2K ﹤0.01% 5594
2015
Q2
$81K Buy
14,122
+1,264
+10% +$7.25K ﹤0.01% 5689
2015
Q1
$75K Sell
12,858
-43,217
-77% -$252K ﹤0.01% 5644
2014
Q4
$440K Buy
56,075
+31,062
+124% +$244K ﹤0.01% 4755
2014
Q3
$123K Buy
25,013
+1,091
+5% +$5.37K ﹤0.01% 5376
2014
Q2
$148K Sell
23,922
-329,528
-93% -$2.04M ﹤0.01% 5305
2014
Q1
$1.89M Buy
353,450
+63,622
+22% +$340K ﹤0.01% 3471
2013
Q4
$1.52M Buy
289,828
+211,936
+272% +$1.11M ﹤0.01% 3595
2013
Q3
$430K Buy
77,892
+61,478
+375% +$339K ﹤0.01% 4434
2013
Q2
$42K Buy
+16,414
New +$42K ﹤0.01% 5217